Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Association of the MMP12 rs652438 Variant with Lung Cancer Susceptibility: A Smoking-Stratified Analysis

MMP12 rs652438, but not rs2276109, was associated with lung cancer susceptibility in this Taiwanese population, and the association was more apparent among ever-smokers, although formal genotype-smoking interaction analyses were not statistically significant.

Te-Chun Shen, Guan-Liang Chen, Liang-Wen Hang et al. · 0 citations
Review Open access Sep 2026

Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA Study.

INTRODUCTION In the phase III LAURA study, osimertinib demonstrated statistically significant improvement in progression-free survival (PFS) versus placebo in patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC) without disease progression during/after chemoradiotherapy. We report pre-sp...

M. Özgüroǧlu, Myung-Ju Ahn, Xiao-Rong Dong et al. · 0 citations
Open access Aug 2026

From Susceptibility to Severity: The Impact of Interleukin-33 rs1929992 Polymorphism on Asthma in a Taiwanese Population

Overall, rs1929992 was associated with asthma susceptibility in this Taiwanese population; however, independent replication and functional studies are required before its biological or clinical relevance can be established.

T. Hsia, Liang-Wen Hang, Te-Chun Shen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.